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A B S T R A C T
Propionibacterium acnes, plays an important role in acne vulgaris and other diseases. However,
understanding of the exact mechanisms of P. acnes pathogenesis is limited. Few studies have investigated
its proteome, which is essential for vaccine development. Here, we comprehensively investigate the
proteome of P. acnes strain ATCC 6919, including secreted, cell wall, membrane, and cytosolic fractions in
three types of growth media. A total of 531 proteins were quantiﬁed using an Orbitrap mass spectrometer
and bioinformatically categorized for localization and function. Several, including PPA1939, a highly
expressed surface and secreted protein, were identiﬁed as potential vaccine candidates.
Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Acne vulgaris is an inﬂammatory disease of the pilosebaceous
unit. With at least 85% prevalence among 12–24 year olds, it can
cause long-term scarring and have a major psychological impact on
individuals [1]. The gram-positive, anaerobic species Propionibac-
terium acnes has been traditionally implicated in the development
of acne vulgaris [2]. It is also a signiﬁcant organism in infections of
the prostate [3], prosthetic joints [4], other surgical implants [5],
spinal discs [6], and ophthalmic infections [7]. Unfortunately, the
bacteria in many cases are resistant to antibiotic therapy [8,9], and
other treatments often have low patient compliance [10]. Thus, the
need exists for novel approaches to develop treatments that are
more effective against P. acnes and have fewer side effects.
A vaccine may be an efﬁcient means to protect against multiple
types of infections caused by P. acnes [11,12]. Several recent studies
have investigated this possibility. Antibodies generated by mouse
intranasal vaccination of heat-killed P. acnes reduced P. acnes-
induced IL-8 inﬂammation and cytotoxicity in sebocytes [13],
though this study used an in vitro experimental system. Vaccina-
tion with heat-killed P. acnes reduced the severity of disease and
inﬂammation in a P. acnes ear infection mouse model. The same
group generated antibodies against P. acnes surface sialidase [14],* Corresponding author at. Division of Dermatology, 52-121CHS, 10833 Le Conte
Ave Los Angeles, CA 90095-1782 United States.
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1876-3820/Published by Elsevier GmbH. This is an open access article under the CC BYwhich had similar effects in sebocytes. Vaccination with the
sialidase [14], as well as with Christie–Atkins–Munch-Peterson
(CAMP) factor 2 [15,16], also successfully reduced inﬂammation in
mouse ear infections. However, this mouse model is not
necessarily representative of the environment in acne vulgaris,
in which an inﬂammatory response may act to either quickly clear
P. acnes, or worsen the disease state. A better in vivo model is
needed to further investigate vaccines.
In addition to its potential protective effects against acne, a P.
acnes-based vaccine may also have other beneﬁcial effects. Heat-
killed P. acnes reduced atopic dermatitis in a mouse model, and
increased the number of Th1 and Treg cells in the spleen [17]. A
heat-killed P. acnes vaccine was also cross-protective against
Actinobacillus pleuropneumoniae infection in mouse and pig
models, inducing cross-reactive antibodies [18]. Speciﬁc P. acnes
proteins could induce cross-reactive antibodies and protection in
the A. pleuropneumoniae mouse model [19]. Intratumoral injection
of live P. acnes was successful in increasing the antitumor
Th1 immune response in a melanoma mouse model [20]. A P.
acnes vaccine improved glomerulosclerosis in a mouse model via a
Th1 response [21]. Several vaccine studies have also utilized P.
acnes as an adjuvant. A microparticle preparation of P. acnes cell
wall increased Th1 response to vaccination [22], and heat-killed P.
acnes increased activation of B-1 lymphocytes [23].
P. acnes remains a largely understudied organism, with little
information available to investigate additional vaccine candidates.
Only four studies have covered the P. acnes proteome, none of
which were comprehensive. Holland et al. examined the secreted-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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differences between types [24]. Dekio et al. identiﬁed several
proteins expressed by P. acnes in anaerobic and microaerophilic
conditions, but not aerobic conditions [25]. Mak et al. assessed the
surface proteome of P. acnes using trypsin shaving, comparing it to
other Propionibacterium species [26]. Bek-Thomsen et al. examined
the proteome of sebaceous follicular casts, which included several
P. acnes proteins [27]. However, none of these studies used a
quantitative method, and only a limited number of proteins could
be detected. A more comprehensive picture of its proteome,
including proteins from all fractions of the cell, may contribute to
our understanding of the molecular mechanisms of P. acnes disease
pathogenesis, in addition to suggesting additional vaccine
candidates. Here, we present a comprehensive study of the
proteome, including surface proteins, secreted proteins, and
intracellular proteins, of P. acnes strain ATCC 6919 (phylotype
IA-2, a group enriched in acne vulgaris patients [28,29]) grown in
three types of media.
2. Methods
2.1. Bacterial culture
P. acnes strain ATCC 6919 (NCTC 737), a commonly used
laboratory strain originally isolated from an acne patient, was
inoculated from glycerol stocks into 10 mL of Reinforced Clostridial
Media (RCM) (Oxoid) and grown at 37 C using AnaeroPack system
sachets (Remel). When bacteria reached the exponential phase of
growth (optical density of 0.1–0.3 at 600 nm wavelength with 1 cm
path length) after 5–6 days, bacteria were collected by centrifuga-
tion and divided evenly into 50 mL of RCM, 50 mL of Brain–Heart
Infusion Broth (BHI) (Oxoid), and 50 mL of BHI supplemented with
5% egg yolk (Sigma) after autoclaving (EBHI). Cultures were again
incubated at 37 C for approximately 40 h using anaerobic sachets,
with shaking at 200 rpm for the cultures in BHI and EBHI. P. acnes
was harvested in the late exponential phase (optical density of
1.0 at 600 nm wavelength with 1 cm path length) for protein
fraction preparation.
2.2. Fraction preparation
P. acnes samples were pelleted by centrifugation at 4000 g for
10 min for the BHI and BHI-E samples and 30 min for the RCM
sample. The supernatant, containing the secreted proteins, was
collected and ﬁltered through 0.2 mm pores, yielding the Cell
Secretion (CS) fraction. The pellets were washed thrice with
phosphate buffered saline (PBS), and divided into four equally
sized samples.
To protoplast the bacteria and release cell wall proteins, a
technique was followed similar to one used by Gallis et al. [30]. One
sample was resuspended in 200 mL of solution containing 10 mM
pH 7 phosphate buffer, 600 mM KCl, 10 mM MgCl2, and 1 mg/mL
egg white lysozyme (Pierce). Another sample was resuspended in
200 mL of solution containing 50 mM Tris–HCl, 250 mM sucrose,
10 mM MgCl2, 30 mM KCl, and 1 mg/mL egg white lysozyme. These
two samples were incubated with rotation at 37 C for 4 h to allow
for lysozyme digestion of cell walls. Samples were then centrifuged
for 5 min at 1000 g with the supernatant retained. Samples were
than centrifuged for 5 min at 20,000 g, and supernatants from the
two fractions were combined. The sample was ﬁltered through
0.2 mm pores, yielding the Cell Wall (CW) fraction.
The remaining two samples were subjected to beadbeating
with a micro-MiniBeadbeater (Biospec Products) for ﬁve minutes
with cooling every minute. Samples were than sonicated. One of
these samples was designated the Total Cell Extract (TCE) fraction.
The other sample was centrifuged at ﬁrst 1000 g for 5 min and thenat 8000 g for ﬁve minutes, with the supernatant retained each
time. The sample was then centrifuged at 20,000 g for 15 min. The
supernatant was designated the Cell Cytosolic (CC) fraction.
Membranes were obtained using a similar protocol to one
developed by Zuobi-Hasona and Brady [31]. The pellet was
washed three times with PBS with centrifugation at 20,000 g for
15 min each, and it was than resuspended in 100 mL of PBS. This
was designated the Cell Membrane (CM) fraction.
2.3. Mass spectrometry
10 mg of protein from the CC and TCE fractions as quantiﬁed
by Bradford assay and all of the CS, CW, and CM protein
samples were adjusted to 20% trichloroacetic acid and
incubated at 4 C for 30 min. Samples were centrifuged at
20,000 g for 5 min, and the pellet was washed with 200 mL of
cold acetone. The pellet was resuspended in a solution of 50%
aqueous 100 mM ammonium bicarbonate and 50% acetonitrile.
Samples were reduced with 25 mM tris-(2-carboxyethyl)-phos-
phine for 30 min at 37 C and then alkylated with 75 mM
iodoacetamide for 1 h at room temperature in the dark. Samples
were diluted to 5% acetonitrile in pH 8100 mM ammonium
bicarbonate buffer and digested for 16 h with 500 ng trypsin
(Promega). Samples were then centrifuged at 20,000 g for
10 min twice, with the supernatant retained. Samples under-
went liquid chromatography and tandem mass spectrometry
using an LTQ Orbitrap XL mass spectrometer (Thermo Fisher)
with NanoLC-2D HPLC (Eksigent). This method has been shown
to be accurate for label-free quantiﬁcation of proteins [32,33].
Reverse phase chromatography on a reverse phase column
(New Objective C18, 15 m, 75 mM diameter) was conducted at
500 nL/min for loading and analytical separation with Buffer A
containing aqueous 0.1% formic acid and Buffer B containing
0.1% formic acid in acetonitrile. Peptides were eluted using a
gradient of 3–40% Buffer B over 3 hours. The Orbitrap was used
in MS/MS mode with a high-resolution full precursor scan and
ten low resolution MS/MS events on the linear trap during the
full scan., The threshold intensity for Collision Induced
Dissociation was 5000 and the allowed mass range was 350–
2000 Da.
2.4. Data analysis
Raw spectral data were processed with RawXtract, and
identiﬁed peptides were analyzed with the ProLuCID algorithm
(V1.3.3) using the database of P. acnes reference strain KPA171202
[34]. No additional unique protein hits were found when using the
type IA P. acnes strain 266 database. Scaffold 4.4.1.1 (Proteome
Software) was used for identiﬁcation and quantiﬁcation of proteins
with a false discovery rate of 5%, allowing for more true
identiﬁcations in the smaller CS and CW datasets than the
standard 1%. Only proteins with at least two unique peptides were
counted. Protein quantiﬁcation was determined by normalized
spectral abundance factors to obtain relative quantiﬁcation of
protein in each sample. All quantities are reported in fmol protein
per microgram of total protein detected. Protein localization was
predicted using the PSORTb 3.0 tool [35], and signal peptides were
predicted using SignalP 4.1 [36]. PSORTb assigns scores for
extracellular, cell wall, membrane, or cytoplasmic localization,
with the sum adding up to 10. A “non-cytoplasmic” PSORTb
localization indicates a zero score for cytoplasmic localization,
while “unknown” indicates no localization prediction. In Table S1,
only the highest score for any fraction is shown. For SignalP, a score
of over 0.45 was indicative of a signal peptide (Y), with scores of
0.35–0.45 listed as probable signal peptides (P), scores of
0.25–0.35 listed as maybe a signal peptide (M), and scores of
Y. Yu et al. / EuPA Open Proteomics 9 (2015) 1–7 3below 0.25 listed as no signal peptide (N). NCBI’s BLAST tool [37]
was used to search for homologs with known function to assist
with functional annotation of protein lists.
3. Results
3.1. Identiﬁcation of Propionibacterium acnes proteins
To investigate the proteome of P. acnes in different environ-
ments, we assessed its proteome in Reinforced Clostridial Media
(RCM) and Brain–Heart Infusion Broth (BHI), common media used
in laboratories. Additionally, we devised EBHI media, BHI
supplemented with 5% egg yolk, to approximate the lipid-rich
environment of the pilosebacous unit. In total, 531 proteins from P.
acnes were identiﬁed and quantiﬁed (Table S1), representing
slightly over 20% of the total number of predicted proteins in its
genome. Of these, 471 were detected in the fractions from P. acnes
grown in Reinforced Clostridial Media RCM, 359 in fractions from
BHI, and 415 in fractions from EBHI. Most proteins were found in all
three growth media groups, including nearly all from BHI fractions
(Fig. 1A).
Cell Secretion (CS) fractions together across the three different
media contained 58 distinct proteins (Fig. 1B). However, very few
proteins were detected in CS fractions from BHI and EBHI media
due to a large amount of precipitate after treatment with
trichloroacetic acid that could not be separated from protein. Cell
Wall (CW) fractions contained 123 distinct proteins across the
three different media. Cell Membrane (CM) fractions contained
310 proteins, though the BHI CM fraction had only 34, signiﬁcantly
fewer than the RCM and EBHI fractions. Cell Cytosolic (CC) fractions
contained 445 proteins. All fractions had signiﬁcant overlap of
proteins with other fractions, but few proteins were present in all
four of these fractions (Fig. 1B). Additionally, the Total Cell Extract
(TCE) fraction contained 347 proteins, of which only 5 were unique
to this fraction. The TCE fraction had a very high degree of overlap
with the CC fraction.
3.2. Protein localization
To assess the purity of our protein fractions, we utilized PSORTb
to predict protein localization and SignalP to predict signal
peptides, which are indicative of a non-cytoplasmic localization.
Both PSORTb and SignalP were in fairly good agreement for non-
cytoplasmic localization, with SignalP more stringent in its
assessments. Of the PSORTb predicted cytoplasmic proteins, onlyFig. 1. Identiﬁed Proteins. Comparison of proteins identiﬁed in different growth med
Abbreviations: RCM—Reinforced Clostridial Media, BHI—Brain–Heart Infusion Broth, EBH
Cell Wall, CM—Cell Membrane, CC—Cell Cytosolic.12 out of 384 proteins (3.1%) had a signal peptide or probable signal
peptide. Of the PSORTb predicted non-cytoplasmic proteins
(including predicted cell wall, extracellular, and membrane
proteins), 35 out of 94 proteins (37.2%) had a signal peptide or
probable signal peptide. For PSORTb unknown proteins, 17 out of
53 proteins (32.1%) had a signal peptide or probable signal peptide,
indicating that the unknown proteins may contain nearly the same
proportion of true non-cytoplasmic proteins and PSORTb predicted
non-cytoplasmic proteins.
The CS fractions were highly enriched for non-cytoplasmic
proteins according to PSORTb, with 31 out of 58 proteins (53.4%)
having non-cytoplasmic (including unknown) localization predic-
tion. In the 20 most abundant CS proteins, the level of enrichment
was even higher (85%) (Table 1). The CW fractions were also
enriched for non-cytoplasmic proteins, with 53 out of 123 proteins
(43.1%) having non-cytoplasmic localization prediction. The level
of enrichment was also higher (60%) for the 20 most abundant CW
proteins (Table 2), not including a phosphocarrier protein that may
have a signal peptide and act as a cell surface transporter. The CM
fractions had 80 out of 310 proteins (25.8%) with non-cytoplasmic
localization prediction. This is only slightly higher than the
proportion in the CC fraction (22.7%). The proportion of non-
cytoplasmic proteins was not further enriched in the most
abundant CM proteins. In the CC fraction, all of the 20 most
abundant proteins had cytoplasmic localization (Table 3).
3.3. Functional analysis
NCBI’s BLAST was used to assess the function of proteins by
homology. Similar proteins were identiﬁed, together with con-
served domains, and this information was used to assess a possible
function of 176 proteins (Table S1). In the CS fractions, 40% of the
30 most abundant proteins were associated with digestion of
protein, lipid, or carbohydrate nutrients (Fig. 2A). Proteins of
unknown function represented 20% of the CS proteins, and 16.7%
were possible surface proteins (involved in cell wall remodeling,
adhesion, transportation, and mobility) that had been released.
The remainder in the CS fraction were cytosolic proteins of varying
function. In the CW fractions, 36.7% of the most abundant
30 proteins were associated with varying cell surface-related
activities including nutrient digestion, adhesion, transportation,
cell wall remodeling, as well as one protein with putative antitoxin
properties (Fig. 2B). Comparatively, 23.3% of the CS proteins were
unknown, and the rest were cytosolic proteins, with ribosomal
proteins particularly well-represented. The CC fraction wasia (A) and different cell fractions (B). Data from one of two similar experiments.
I—5% Egg Yolk Supplemented Brain Heart Infusion Broth, CS—Cell Secretion, CW—
Table 1
The 20 most abundant secreted proteins.
Protein Accession (gi) MW (kDa) RCM fmol BHI fmol EBHI fmol SignalP PSORTb Function
Protein PPA1939 50843388 17 6222 58824 6757 Y Unknown Unknown
Adhesion 50843565 42 50 0 19238 M Unknown Adhesion
cAMP factor 50842175 29 3408 0 2660 Y Extracellular Digestion
Protein PPA2239 50843674 41 1996 0 0 Y Non-Cytoplasmic Digestion
Protein PPA2271 50843708 52 1415 0 0 Y Unknown Digestion
Endoglycoceramidase 50842131 57 1351 0 0 Y Non-Cytoplasmic Digestion
Protein PPA1746 50843206 22 1218 0 0 Y Non-Cytoplasmic Unknown
NPL/P60 protein 50842209 41 1100 0 0 Y Membrane Digestion
Cell wall hydrolase 50843410 43 986 0 0 M Extracellular Digestion
Protein PPA1745 50843205 90 979 0 0 M Extracellular Digestion
cAMP factor 50842820 30 685 0 0 Y Extracellular Digestion
Chaperone GroEL 50841936 57 662 0 0 N Cytoplasmic Protein folding
Triacylglycerol lipase 50843543 36 642 0 0 Y Non-Cytoplasmic Digestion
Protein PPA0533 50842017 20 599 0 0 Y Non-Cytoplasmic Unknown
co-chaperonin GroES 50843233 11 595 0 0 N Cytoplasmic Protein folding
Endoglycoceramidase 50843544 54 571 0 0 Y Non-Cytoplasmic Digestion
Fine tangled pili 50843572 19 436 0 0 N Cytoplasmic Mobility
Lipase/acylhydrolase 50843480 30 377 0 0 P Unknown Digestion
Regulatory protein 50842205 39 325 0 0 P Unknown Translation
Protein PPA1715 50843175 49 309 0 0 Y Non-Cytoplasmic Unknown
Table shows quantity in femtomoles per microgram of total protein detected. SignalP predictions are yes (Y), probably (P), maybe (M), and no (N). Abbreviations: RCM—
Reinforced Clostridial Media, BHI—Brain Heart Infusion Broth, EBHI—5% Egg Yolk Supplemented Brain Heart Infusion Broth. Data from one of two similar experiments.
4 Y. Yu et al. / EuPA Open Proteomics 9 (2015) 1–7dominated by proteins involved in metabolism, translation, and
protein folding, with signiﬁcant numbers of proteins involved in
synthesis and DNA structure (Fig. 2C).
4. Discussion
By examining the proteome in three different types of growth
media, we can gain insight into which proteins may be expressed
in a wide variety of environments in vivo, including the piloseba-
ceous unit in acne and those environments in other P. acnes
infections. RCM and BHI are common media used to culture P. acnes
in vivo, but these do not provide a lipid-rich environment to
approximate the pilosebacous gland. Thus, we investigated a third
media, EBHI, which uses egg yolk as a source of lipids. Of note, a
large number of proteins were expressed by P. acnes in all three
types of media, indicating that its proteome is largely conserved
between different environments. This may be due to the small
ecological niche that P. acnes occupies, reducing its need for an
ability to signiﬁcantly change its proteome for differentTable 2
The 20 most abundant cell wall proteins.
Protein Accession (gi) MW (kDa) RCM fmol BHI f
co-chaperonin GroES 50843233 11 5024 251 
Protein PPA1939 50843388 17 2799 1799
Membrane lipoprotein 50843218 34 91 4124
Adhesion 50843565 42 2553 0 
Protein PPA2271 50843708 52 800 1948
Protein PPA2334 50843769 126 0 4210
DNA-binding HU 50843144 10 1948 749 
CsbD-like protein 50842907 7 2477 635 
Protein PPA1281 50842762 30 1297 219 
Peptide transporter 50843590 61 1311 0 
Phosphocarrier HPr 50841838 9 1424 508 
Protein PPA1018 50842501 7 1033 271 
Protein PPA1715 50843175 49 1265 384 
Rare lipoprotein A 50843612 37 0 1553
Protein PPA0542 50842026 18 510 0 
50S ribosomal L29 50843310 9 1052 246 
Adhesion 50843645 48 45 0 
tRNA synthetase 50842977 64 0 0 
30S ribosomal S15 50842951 10 604 238 
30S ribosomal S18 50843663 9 155 333 
Table shows quantity in femtomoles per microgram of total protein detected. SignalP p
Reinforced Clostridial Media, BHI—Brain Heart Infusion Broth, EBHI—5% Egg Yolk Suppenvironments. Since most of those conserved proteins identiﬁed
in vitro across media types would likely be expressed in vivo, our
ﬁndings may also apply to the P. acnes proteome in the
pilosebacous unit, and thus easing the identiﬁcation of good
vaccine candidates. Indeed, the proteins detected in vivo by Bek-
Thomsen et al. were among the most abundant in our in vitro
fractions [27]. Nevertheless, we did detect a few interesting
differences between media types. In BHI media, we found lower
expression of some adhesion proteins (50843565, 50843645) and
lipases (50843205, 50843480, 50843543), perhaps reﬂective of the
increased nutrient density and variety in EBHI and especially RCM.
One CAMP factor was also not found in the CS and CW fractions of
BHI, but it was abundant in RCM and EBHI.
The CS and CW fractions contained many proteins with
“unknown” or “non-cytoplasmic” localization prediction according
to PSORTb. It seems likely that the bulk of these proteins are true
secreted proteins or cell wall proteins, implying that the PSROTb
program can be further reﬁned for greater predictive accuracy for
these types of proteins. Also many proteins with predictedmol EBHI fmol SignalP PSORTb Functional group
2008 N Cytoplasmic Protein folding
 1555 Y Unknown Unknown
 1924 M Membrane Transportation
3283 M Unknown Adhesion
 1539 Y Unknown Digestion
 0 N Cytoplasmic Unknown
1427 N Cytoplasmic Miscellaneous
743 N Unknown Unknown
1754 M Non-Cytoplasmic Unknown
1813 Y Cell Wall Transportation
240 M Cytoplasmic Transportation
696 N Unknown Miscellaneous
96 Y Non-Cytoplasmic Unknown
 113 Y Non-Cytoplasmic Cell wall structure
960 Y Non-Cytoplasmic Cell unknown
139 N Cytoplasmic Translation
1356 P Cell Wall Adhesion
1369 N Cytoplasmic Synthesis
526 N Cytoplasmic Translation
766 M Cytoplasmic Translation
redictions are yes (Y), probably (P), maybe (M), and no (N). Abbreviations: RCM—
lemented Brain Heart Infusion Broth. Data from one of two similar experiments.
Table 3
The 20 most abundant cytoplasmic proteins.
Protein Accession (gi) MW (kDa) RCM fmol BHI fmol EBHI fmol SignalP PSORTb Functional group
GAPDH 50842303 36 943 1270 1013 N Cytoplasmic Metabolism
co-chaperonin GroES 50843233 11 1206 1108 605 N Cytoplasmic Protein folding
Phosphopyruvate hydratase 50842029 46 680 1193 699 N Cytoplasmic Metabolism
50S ribosomal L7/L12 50843339 14 546 816 695 N Cytoplasmic Translation
Elongation factor Tu 50843327 44 649 795 480 N Cytoplasmic Translation
Fructose-bisphosphate aldolase 50843457 37 430 605 681 N Cytoplasmic Metabolism
Phosphoglyceromutase 50841849 28 519 573 523 N Cytoplasmic Metabolism
Aspartate aminotransferase 50841624 39 443 478 568 N Cytoplasmic Synthesis
Molecular chaperone GroEL 50843232 56 755 368 349 N Cytoplasmic Protein folding
DNA-binding protein HU 50843144 10 351 539 517 N Cytoplasmic DNA structure
Molecular chaperone GroEL 50841936 57 637 261 382 N Cytoplasmic Protein folding
Phosphoglycerate kinase 50842304 42 262 476 456 N Cytoplasmic Metabolism
Malate dehydrogenase 50843200 35 367 298 427 N Cytoplasmic Metabolism
Molecular chaperone DnaK 50843484 66 379 265 430 M Cytoplasmic Protein folding
Elongation factor Ts 50842998 28 249 374 378 N Cytoplasmic Translation
Hypothetical protein PPA0277 50841766 12 45 555 311 N Cytoplasmic DNA structure
Polynucleotide phosphorylase 50842950 79 225 301 356 N Cytoplasmic Miscellaneous
Fine tangled pili 50843572 19 381 189 282 N Cytoplasmic Mobility
Ornithine carbamoyltransferase 50842070 37 386 179 234 N Cytoplasmic Synthesis
Triosephosphate isomerase 50842305 27 213 241 330 N Cytoplasmic Metabolism
Table shows quantity in femtomoles per microgram of total protein detected. SignalP predictions are yes (Y), probably (P), maybe (M), and no (N). Abbreviations: RCM—
Reinforced Clostridial Media, BHI—Brain Heart Infusion Broth, EBHI—5% Egg Yolk Supplemented Brain Heart Infusion Broth. Data from one of two similar experiments.
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including several transporters. While lysozyme digestion of the
cell wall should have left the membrane intact, it is possible that
some membrane proteins may have components embedded in the
cell wall that were released upon cell wall disruption.
There were several proteins of predicted cytoplasmic localization
in our CS and CW fractions, several of which have been seen in
previous studies [24,26]. While some of these are likely contami-
nants, natural autolysis of P. acnes could result in many of these
proteins being released into the media and later binding to the
surface of the bacteria. Additionally, these proteins may have dual
roles outside of the cytoplasm, and may be secreted by non-
traditional pathways, accounting for their cytoplasmic localization
prediction. Furthermore, many abundant CC proteins were not
found in CS and CW fractions, indicating that those possible
contaminating proteins represent only a subfraction of likely
contaminants and thus, are largely not contaminants at all. Finally,
functional analysis of CS and CW proteins indicates that these
prediction programs are likely accurate, since they predicted that
proteins with expected secreted and cell wall functions were non-
cytoplasmic.
More reﬁned methods are needed to obtain pure CM fractions of
P. acnes. Even protocols utilizing ultracentrifugation yielded noFig. 2. Protein Functional Analysis. Functional analysis of the 30 most abundant prot
Abbreviations: CS—Cell Secretion, CW—Cell Wall, CC—Cell Cytosolic.improvement in purity. However, it should be noted that while the
CC and TCE fractions have a very high degree of overlap, the CM
fraction has a fair number of unique protein identiﬁcations in
comparison, implying that this protein fraction is distinctly
different from a purely cytosolic fraction, which would be the
case if contaminants completely dominated the CM fraction.
The RCM CS fraction shared many highly expressed proteins in
common with a study on the P. acnes secretome by Holland et al.
[24]. While not directly comparable due to the different type of
media used, the fact that similar highly expressed proteins were
found in both studies and in a separate in vivo study [27] supports
both methods used. While Holland et al.’s method of 2D gel
digestion allowed for use of BHI, and their earlier exponential
phase cultures allowed for higher purity (fewer cytosolic proteins,
likely due to less autolysis), our use of in-solution digestion
followed by assessment with an Orbitrap mass spectrometer
allowed for many more proteins to be both identiﬁed and
quantiﬁed. These same conclusions apply to the study of the cell
wall proteome by Mak et al. [26], where many of the same highly
expressed P. acnes proteins were also detected in both studies.
With regard the existing vaccine candidates, the most highly
expressed CAMP factor (50842175) detected in our fractions was
the same protein used in a vaccine to reduce inﬂammation in aeins in the secreted fraction (A), cell wall fraction (B), and cytosolic fraction (C).
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which conferred similar vaccine protection [14], was not detected
in our protein fractions or in the in vivo study of Bek-Thomsen et al.
[27]. The CAMP factor protein may therefore have a higher
probability of in vivo expression in the pilosebaceous environment.
Several proteins from P. acnes were found to confer vaccine
protection in mice against A. pleuropneumoniae [19]. The most
efﬁcient of these was a single-stand DNA binding protein
(50843664), which was detected at moderate level in our CC
fraction. Phage shock protein A (50842186), the second-most
efﬁcient vaccine in the mouse model, was detected at a somewhat
lower level in the CC fraction. All other proteins in their study were
also detected in our CC fraction in varying quantity, indicating that
they may be also be used in a P. acnes-based vaccine as well.
Several highly expressed surface and secreted proteins detected
in our study are of potential future interest for functional studies or
vaccine candidates. These include the PPA1939 protein (50843388)
of unknown function, which was the most abundant secreted
protein, and among the most abundant in the cell wall. Other
surface proteins that are highly expressed and may make good
vaccine candidates include DsA1, an adhesion/S-layer protein
(50843565), and a probable transporter lipoprotein (50843218).
Since P. acnes is a commensal organism and acne is an
inﬂammatory disease, it may be preferable for an acne vaccine
candidate to induce a strong Treg response, rather than the more
common Th1, Th17, or antibody response. Thus, several vaccine
candidates would need thorough assessment using human cells to
ﬁnd one suitable for use in acne. These same highly expressed
surface and secreted proteins may be potential virulence factors.
Further research to determine their function may allow for greater
understanding of the mechanisms of pathogenesis in acne.
We investigated P. acnes strain ATCC 6919, a MLST phylotype IA1
[9,29] and whole-genome phylotype IA-2 [38] strain of P. acnes.
Many other phylotypes are of potential interest, since they have
been recently shown to have differing disease associations,
including for acne vulgaris [28,29,39]. We are currently character-
izing the full proteome of several of these phylotypes.
5. Conclusions
Our study presents a comprehensive overview of the P. acnes
proteome, with proteins identiﬁed and quantiﬁed using an
Orbitrap mass spectrometer. In addition to cytoplasmic proteins,
we also identiﬁed several dozen secreted and cell wall proteins,
which were analyzed for predicted localization and function. Our
identiﬁed cell wall proteins, due to their surface localization,
represent potential vaccine candidates.
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